Your Article Summary
CEL-SCI Hires Clinical Research Organization For Clinical Study With Hospitalized H1N1-Infected Patients
CEL-SCI, 10/21/09
CEL–SCI Corporation, a developer of vaccines and therapeutics for the treatment of infectious diseases and a late–stage oncology company, announced that it has hired a full–service Clinical Research Organization with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS–H1N1 treatment.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Article Search
Sponsor


See Latest Articles


